Carcinome canalaire in situ (CCIS) chez les femmes de moins de 40 ans : une prise en charge particulière ?

Bijker, 2006, J Clin Oncol, 24, 3381, 10.1200/JCO.2006.06.1366 Fisher, 1996, Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Five-year observations concerning lobular carcinoma in situ, Cancer, 78, 1403, 10.1002/(SICI)1097-0142(19961001)78:7<1403::AID-CNCR6>3.0.CO;2-L Houghton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial, Lancet, 362, 95, 10.1016/S0140-6736(03)13859-7 Cutuli, 2001, Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients, Eur J Cancer, 37, 2365, 10.1016/S0959-8049(01)00303-3 Sahoo, 2005, Defining negative margins in DCIS patients treated with breast conservation therapy: the University of Chicago experience, Breast J, 11, 242, 10.1111/j.1075-122X.2005.21617.x Schouten van der Velden, 2006, Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age, Ann Surg Oncol, 13, 990, 10.1245/ASO.2006.05.044 Solin, 1996, Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast, J Clin Oncol, 14, 754, 10.1200/JCO.1996.14.3.754 Tunon-de-Lara, 2001, Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment: the experience of one institute, Am J Clin Oncol, 24, 531, 10.1097/00000421-200112000-00001 Van Zee, 1999, Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age, Cancer, 86, 1757, 10.1002/(SICI)1097-0142(19991101)86:9<1757::AID-CNCR18>3.0.CO;2-V Vicini, 2000, Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy, J Clin Oncol, 18, 296, 10.1200/JCO.2000.18.2.296 de Bock, 2006, Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies, Eur J Cancer, 42, 351, 10.1016/j.ejca.2005.10.006 El Saghir, 2006, Effects of young age at presentation on survival in breast cancer, BMC Cancer, 6, 194, 10.1186/1471-2407-6-194 Goldhirsch, 2001, Adjuvant therapy for very young women with breast cancer: need for tailored treatments, J Natl Cancer Inst Monogr, 44, 10.1093/oxfordjournals.jncimonographs.a003459 Vujovic, 2006, The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up, Int J Radiat Oncol Biol Phys, 66, 687, 10.1016/j.ijrobp.2006.05.051 Shimauchi, 2005, Long-term outcome of breast-conserving therapy for breast cancer, Radiat Med, 23, 485 Neff, 1996, Long-term results of breast conservation therapy for breast cancer, Ann Surg, 223, 709, 10.1097/00000658-199606000-00009 Bijker, 2001, Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of european organization for research and treatment of cancer trial 10853, J Clin Oncol, 19, 2263, 10.1200/JCO.2001.19.8.2263 Fowble, 1997, Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS), Int J Radiat Oncol Biol Phys, 38, 949, 10.1016/S0360-3016(97)00153-3 Boyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.0.CO;2-7 Silverstein, 2003, The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast, Am J Surg, 186, 337, 10.1016/S0002-9610(03)00265-4 Omlin, 2006, Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the rare cancer network, Lancet Oncol, 7, 652, 10.1016/S1470-2045(06)70765-3 Cutuli, 2005, Standards options and recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004, Bull Cancer, 92, 155 Durieux, 2006, Prognosis of operable breast cancer in young patients treated in a single institution: independant pejorative value of positive estrogen receptor, Eur J Cancer, S130, 10.1016/S1359-6349(06)80305-8 Bertheau, 1999, Breast cancer in young women: clinicopathologic correlation, Semin Diagn Pathol, 16, 248 Zabicki, 2006, Breast cancer diagnosis in women less or equal to 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time, Ann Surg Oncol, 13, 1072, 10.1245/ASO.2006.03.055 Solin, 2001, Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status, Int J Radiat Oncol Biol Phys, 50, 991, 10.1016/S0360-3016(01)01517-6 Goldstein, 2000, Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age, Cancer, 88, 2553, 10.1002/1097-0142(20000601)88:11<2553::AID-CNCR18>3.0.CO;2-V Rodrigues, 2003, Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women, Cancer, 97, 1393, 10.1002/cncr.11204 Vicini, 2002, Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature, J Clin Oncol, 20, 2736, 10.1200/JCO.2002.07.137 Ohtake, 1995, Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems, Cancer, 76, 32, 10.1002/1097-0142(19950701)76:1<32::AID-CNCR2820760106>3.0.CO;2-R Fisher, 2007, Pathologic variables predictive of breast events in patients with ductal carcinoma in situ, Am J Clin Pathol, 128, 86, 10.1309/WH9LA543NR76Y29J Sakorafas, 2003, Optimal management of ductal carcinoma in situ of the breast, Surg Oncol, 12, 221, 10.1016/S0960-7404(03)00031-8 Schwartz, 2000, The Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22–25, 1999, Hum Pathol, 31, 131, 10.1016/S0046-8177(00)80212-9 Szelei-Stevens, 2000, The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy, Int J Radiat Oncol Biol Phys, 48, 943, 10.1016/S0360-3016(00)00715-X Mokbel, 2003, Current management of ductal carcinoma in situ of the breast, Int J Clin Oncol, 8, 18, 10.1007/s101470300001 Spiegel, 2003, Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction, Plast Reconstr Surg, 111, 706, 10.1097/01.PRS.0000041440.12442.05 Ananian, 2004, Determinants of patients’ choice of reconstruction with mastectomy for primary breast cancer, Ann Surg Oncol, 11, 762, 10.1245/ASO.2004.11.027 Fourquet AZ, Campana BF, et al. Institut Curie experience. Baltimore, MD Williams and Wilkins ed, 1997. Darvishian, 2003, Significance of linear extent of breast carcinoma at surgical margin, Ann Surg Oncol, 10, 48, 10.1245/ASO.2003.05.030 Gage, 1996, Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy, Cancer, 78, 1921, 10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-# MacDonald, 2005, Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins, Am J Surg, 190, 521, 10.1016/j.amjsurg.2005.06.005 Fisher, 1995, Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The national surgical adjuvant breast and bowel project collaborating investigators, Cancer, 75, 1310, 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G Cao, 2005, Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions, Am J Surg Pathol, 29, 1625, 10.1097/01.pas.0000180448.08203.70 Chagpar, 2003, Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery, Am J Surg, 186, 371, 10.1016/S0002-9610(03)00264-2 Vicini, 2001, Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy, J Surg Oncol, 76, 245, 10.1002/jso.1041 Silverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V Silverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056/NEJM199905133401902 Hwang, 1998, Volume of resection in patients treated with breast conservation for ductal carcinoma in situ, Ann Surg Oncol, 5, 757, 10.1007/BF02303488 Ikeda, 1998, The current status of the treatment of ductal carcinoma in situ of Japanese women. Especially breast conserving operation in relation to the surgical margin and short term outcome, Breast Cancer, 5, 53, 10.1007/BF02967415 Imamura, 2000, Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age, Breast Cancer Res Treat, 62, 177, 10.1023/A:1006462328544 Antonini, 2007, Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882, Radiother Oncol, 82, 265, 10.1016/j.radonc.2006.09.014 Solin, 2005, Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast, Cancer, 103, 1137, 10.1002/cncr.20886 Yerushalmi, 2006, Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?, Neoplasma, 53, 507 Tunon-de-Lara, 2008, Sentinel node procedure is warranted in ductal carcinoma in situ (DCIS) with high risk of occult invasive carcinoma and micro invasive carcinoma (DCIS MIC) treated by mastectomy, Breast J, 14, 135, 10.1111/j.1524-4741.2007.00543.x Cox, 2001, Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?, Am Surg, 67, 513, 10.1177/000313480106700604 Farkas, 2004, An argument against routine sentinel node mapping for DCIS, Am Surg, 70, 13, 10.1177/000313480407000103 Fuhrman, 2004, Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications, Am Surg, 70, 403, 10.1177/000313480407000506 Goyal, 2006, Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases, Breast Cancer Res Treat, 10.1007/s10549-006-9167-2 Intra, 2003, Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast, Arch Surg, 138, 309, 10.1001/archsurg.138.3.309 Kelly, 2003, Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ, Am J Surg, 186, 368, 10.1016/S0002-9610(03)00276-9 Klauber-DeMore, 2000, Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?, Ann Surg Oncol, 7, 636, 10.1007/s10434-000-0636-2 Mabry, 2006, What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?, Am J Surg, 192, 455, 10.1016/j.amjsurg.2006.06.028 Moran, 2007, Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients, Am J Surg, 194, 172, 10.1016/j.amjsurg.2006.11.027 Pendas, 2000, Sentinel node biopsy in ductal carcinoma in situ patients, Ann Surg Oncol, 7, 15, 10.1007/s10434-000-0015-z Fisher, 1999, Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial, Lancet, 353, 1993, 10.1016/S0140-6736(99)05036-9 Fisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience, Semin Oncol, 28, 400, 10.1016/S0093-7754(01)90133-2 Cuzick, 2002, First results from the international breast cancer intervention study (IBIS-I): a randomised prevention trial, Lancet, 360, 817, 10.1016/S0140-6736(02)09962-2 Mokbel, 2003, Towards optimal management of ductal carcinoma in situ of the breast, Eur J Surg Oncol, 29, 191, 10.1053/ejso.2002.1425 Cutuli, 2002, Breast-conserving therapy for ductal carcinoma in situ of the breast: the French cancer centers’ experience, Int J Radiat Oncol Biol Phys, 53, 868, 10.1016/S0360-3016(02)02834-1 Tunon-de-Lara, 2002, Ductal carcinoma in situ of the breast for women under forty: predictive factors of relapse in a series of 164 cases, Eur J Cancer, S117, 10.1016/S0959-8049(02)80382-3